Medindia

X

Foundation Medicine Expands Molecular Information Decision Support Offerings With GeneKit

by Shirley Johanna on  September 16, 2015 at 6:43 PM General Health News   - G J E 4
Foundation Medicine announced the expansion of its suite of molecular information-based products with GeneKitTM.

GeneKitTM is a genomics solutions portal for pathologists that is uniquely differentiated by the power of FoundationCORETM.
Foundation Medicine Expands Molecular Information Decision Support Offerings With GeneKit
Foundation Medicine Expands Molecular Information Decision Support Offerings With GeneKit
Advertisement

GeneKit is a cloud-based software solution that complements Interactive Cancer Explorer (ICE 2) with PatientMatchTM, which is the company's innovative physician-facing decision support portal.

Advertisement
GeneKit facilitates the interpretation of genomic data generated by pathologists from targeted next generation sequencing (NGS) and "hot spot" assays.

This integration allows pathologists to more effectively support clinical diagnosis and treatment strategies through the rapid interpretation and efficient reporting of genomic information to oncology care teams.

"To ensure that molecular information is used to inform therapeutic decisions and improve patient care, we are offering pathologists a sophisticated clinical interpretation system. GeneKit will allow pathologists to assess a patient's specific tumor alterations against a knowledgebase of curated genomic variants, relevant scientific research, targeted therapy and clinical trial information, enabling the creation of actionable reports in a timely fashion for care teams," said David J. Daly, chief commercial officer of Foundation Medicine.

"Today, a large number of institutions use manual interpretation procedures that can be incredibly arduous, technical and time-consuming. GeneKit overcomes these challenges of manual reporting and furnishes pathologists with highly relevant clinical and scientific data for the betterment of patient care," said David J. Daly.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: